The murine inbred strain C3H provides an experimental model of inherited predisposition to hepatocellular cancer. Hepatocellular neoplastic lesions induced by chemical carcinogens reach a volume 10-100-fold greater in C3H mice than in genetically resistant strains. However, the huge strain differences in tumor size are explained by relatively small differences (10%-30%) in tumor cell kinetics. Genetic linkage experiments in different crosses demonstrated that six unlinked hepatocarcinogen sensitivity (Hcs) and two hepatocarcinogen resistance (Hcr) loci determined quantitative variations in susceptibility to hepatocarcinogenesis. Such results provide the genetic basis for the strain variations in susceptibility to hepatocarcinogenesis and demonstrate a new model of polygenic inheritance of predisposition to cancer.
BennettL.M., FarnhamP.J., DrinkwaterN.R.: Strain-dependent differences in DNA synthesis and gene expression in the regenerating livers of C57BL/6J and C3H/HeJ mice.Mol. Carcinogen., 14: 46–52, 1995.
2.
BuchmannA., Bauer-HofmannR., MahrJ., DrinkwaterN.R., LuzA., SchwarzM.: Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.Proc. Natl. Acad. Sci. USA, 88: 911–915, 1991.
3.
BuchmannA., MahrJ., Bauer-HofmannR., SchwarzM.: Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mouse.Mol. Carcinogen., 2: 121–125, 1989.
4.
BuetowK.H., MurrayJ.C., IsraelJ.L., LondonW.T., SmithM., KewM., BlanquetV., BrechotC., RedekerA., GovindarajahS.: Loss of heterozygosity suggests tumor suppressor genes responsible for primary hepatocellular carcinoma.Proc. Natl. Acad. Sci. USA, 86: 8852–8856, 1989.
5.
CanzianF., UshijimaT., SerikawaT., WakabayashiK., SugimuraT., NagaoM.: Instability of microsatellites in rat colon tumors induced by heterocyclic amines.Cancer Res., 54: 6315–6317, 1994.
6.
Della PortaG., CapitanoJ., ParmiL., ColnaghiM.I.: Urethan carcinogenesis in newborn, suckling, and adult mice of C57BL, C3H, BC3F1, C3Hf and SWR strains.Tumori, 53: 81–102, 1967.
7.
De MunterH.K., Den EngelseL., EmmelotP.: Studies on lung tumors. IV. Correlations between [3H]thymidine labelling of lung and liver cells and tumor formation in GRS/A and C3Hf/A male mice following administration of dimethylnitrosamine.Chem. Biol. Interact., 24: 299–316, 1979.
8.
DraganiT.A.: Analysis of tumor incidence in BALB/c mice used as controls in carcinogenicity experiments.Tumori, 65: 665–675, 1979.
9.
DraganiT.A., ManentiG., ColomboB.M., FalvellaF.S., GariboldiM., PierottiM.A., Della PortaG.: Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.Oncogene, 6: 333–338, 1991.
10.
DraganiT.A., ManentiG., Della PortaG.: Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytes.J. Cancer Res. Clin. Oncol., 113: 223–229, 1987.
11.
DraganiT.A., ManentiG., Della PortaG.: Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice.Cancer Res., 51: 6299–6303, 1991.
12.
DraganiT.A., SozziG., Della PortaG.: Spontaneous and urethan-induced tumor incidence in B6C3F1 versus B6CF1 mice.Tumori, 70: 485–490, 1984.
13.
DrinkwaterN.R., GinslerJ.: Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ.Carcinogenesis, 7: 1701–1707, 1986.
14.
EmiM., FujiwaraY., NakajimaT., TsuchiyaE., TsudaH., HirohashiS., MaedaY., TsurutaK., MiyakiM., NakamuraY.: Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.Cancer Res., 52: 5368–5372, 1992.
15.
EngC., PonderB.A.J.: The role of gene mutations in the genesis of familial cancers.FASEB J., 7: 910–919, 1993.
16.
FernandezE., La VecchiaC., D'AvanzoB., NegriE., FranceschiS.: Family history and the risk of liver, gallbladder, and pancreatic cancer.Cancer Epidemiol. Biomarkers Prevention, 3: 209–212, 1994.
17.
FlaksA.: The susceptibility of various strains of neonatal mice to the carcinogenic effects of 9,10-dimethyl-1,2-benzanthracene.Eur. J. Cancer, 4: 579–585, 1968.
GariboldiM., ManentiG., CanzianF., FalvellaF.S., PierottiM.A., Della PortaG., BinelliG., DraganiT.A.: Chromosome mapping of murine susceptibility loci to liver carcinogenesis.Cancer Res., 53: 209–211, 1993.
20.
GoldsteinA.M., DracopoliN.C., EngelsteinM., FraserM.C., ClarkW.H., TuckerM.A.: Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.Am. J. Hum. Genet., 54: 489–496, 1994.
21.
GoldsteinA.M., DracopoliN.C., HoE.C., FraserM.C., KearnsK.S., BaleS.J., McBrideO.W., ClarkW.H., TuckerM.A.: Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity.Am. J. Hum. Genet., 52: 537–550, 1993.
22.
HaniganM.H., KempC.J., GinslerJ.J., DrinkwaterN.R.: Rapid growth of preneoplastic lesions in hepatocarcinogen-sensitive C3H/HeJ male mice relative to C57BL/6J male mice.Carcinogenesis, 9: 885–890, 1988.
23.
HappleR.: Gregor Mendel and the dysplastic nevus syndrome.Hautarzt, 40: 70–76, 1989.
24.
HsuL-C., GouldM.N.: Cloning and characterization of overexpressed genes in the mammary gland of rat strains carrying the mammary carcinoma suppressor (Mcs) gene.Cancer Res., 53: 5766–5774, 1993.
25.
JiricnyJ.: Colon cancer and DNA repair: have mismatches met their match.Trends Genet., 10: 164–168, 1994.
26.
KennedyG.C., GermanM.S., RutterW.J.: The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription.Nature Genet., 9: 293–298, 1995.
27.
LeeG.H., BennettL.M., CarabeoR.A., DrinkwaterN.R.: Identification of hepatocarcinogen-resistance genes in DBA/2 mice.Genetics, 139: 387–395, 1995.
28.
LeeG-H., NomuraK., KitagawaT.: Comparative study of diethylnitrosamine-initiated two-stage hepatocarcinogenesis in C3H, C57BL and BALB mice promoted by various hepatopromoters.Carcinogenesis, 10: 2227–2230, 1989.
29.
ManentiG., BinelliG., GariboldiM., CanzianF., De GregorioL., FalvellaF.S., DraganiT.A., PierottiM.A.: Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice.Genomics, 23: 118–124, 1994.
30.
ManentiG., De GregorioL., GariboldiM., DraganiT.A., PierottiM.A.: Analysis of loss of heterozygosity in murine hepatocellular tumors.Mol. Carcinogen., 13: 191–200, 1995.
31.
MikiY., SwensenJ., Shattuck-EidensD., FutrealP.A., HarshmanK., TavtigianS., LiuQ., CochranC., BennettL.M., DingW., BellR., RosenthalJ., HusseyC., TranT., McClureM., FryeC., HattierT., PhelpsR., Haugen-StranoA., KatcherH., YakumoK., GholamiZ., ShafferD., StoneS.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science, 266: 66–71, 1994.
32.
MiyasakaK., OhtakeK., NomuraK., KandaH., KominamiR., MiyashitaN., KitagawaT.: Frequent loss of heterozygosity on chromosome 4 in diethynitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture.Mol. Carcinogen., 13: 37–43, 1995.
33.
MurakamiY., HayashiK., HirohashiS., SekiyaT.: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.Cancer Res., 51: 5520–5525, 1991.
34.
NaitoM., NaitoY., ItoA.: Effect of phenobarbital on the development of tumors in mice treated neonatally with N-ethyl-N-nitrosourea.Gann, 73: 111–114, 1982.
35.
OkamotoM., OhtsuH., MiyakiM., YonekawaH.: No allelic loss at the p53 locus in 1,2-dimethylhydrazine-induced mouse colon tumors: PCR-SSCP analysis with sequence-tagged microsatellite site primers.Carcinogenesis, 14: 1483–1486, 1993.
36.
PereiraM.A.: Comparison in C3H and C3B6F1 mice of the sensitivity to diethylnitrosamine-initiation and phenobarbitalpromotion to the extent of cell proliferation.Carcinogenesis, 14: 299–302, 1993.
37.
ShridharV., SiegfriedJ., HuntJ., del Mar AlonsoM., SmithD.I.: Genetic instability of microsatellite sequences in many non-small cell lung carcinomas.Cancer Res., 54: 2084–2087, 1994.
38.
VesselinovitchS.D., RaoK.V.N., MihailovichN., RiceJ.M., LombardL.S.: Development of a broad spectrum of tumors by ethylnitrosourea in mice and the modifying role of age, sex, and strain.Cancer Res., 34: 2530–2538, 1974.
39.
WangH.P., RoglerC.E.: Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas.Cytogenet. Cell Genet., 48: 72–78, 1988.
40.
WeissJ., GarbeC., ButtnerP., JungE.G.: Dysplastic nevi-dysplastic nevus syndromes: clinical features and genetic aspects.Recent Results Cancer Res., 128: 101–118, 1993.
41.
WilliamsE.D., WarehamK.A., HowellS.: Direct evidence for the single cell origin of mouse liver cell tumors.Br. J. Cancer, 47: 723–726, 1983.
42.
WilsonM.S., WestC.M.L., WilsonG.D., RobertsS.A., JamesR.D., SchofieldP.F.: Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.Br. J. Cancer, 68: 501–506, 1993.
43.
WilsonM.S., WestC.M.L., WilsonG.D., RobertsS.A., JamesR.D., SchofieldP.F.: An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers.Br. J. Cancer, 67: 754–759, 1993.
44.
ZerbanH., RadigS., Kopp-SchneiderA., BannaschP.: Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability.Carcinogenesis, 15: 2467–2473, 1994.
45.
ZhangW., HirohashiS., TsudaH., ShimosatoY., YokotaJ., TeradaM., SugimuraT.: Frequent loss of heterozygosity on chromosome 16 and 4 in human hepatocellular carcinoma.Jpn. J. Cancer Res., 81: 108–111, 1990.
